SCHEMBL7120002

SCHEMBL7120002

CC(=O)Nc1ccc(-c2csc(NC(=O)c3cc([N+](=O)[O-])ccc3Cl)n2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.66
MAPT P10636 7/20 0.57
KMT2A Q03164 7/20 0.57
POLB P06746 1/20 0.56
ABL1 P00519 2/20 0.55
MEN1 O00255 6/20 0.55
ALDH1A1 P00352 3/20 0.55
KDM4E B2RXH2 1/20 0.55
PPARG P37231 3/20 0.54
CYP3A4 P08684 3/20 0.54
MAPK1 P28482 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
ALOX15 P16050 1/20 0.54
PPARA Q07869 1/20 0.54
LMNA P02545 2/20 0.54
GFER P55789 1/20 0.54
RORC P51449 2/20 0.54
CYP1A2 P05177 2/20 0.54
CYP2C9 P11712 2/20 0.54
CYP2C19 P33261 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7130746 0.96 RAB9A (0.69) RAB9AMAPTKMT2APOLBABL1
SCHEMBL7128929 0.92 RAB9A (0.67) RAB9AMAPTKMT2APOLBMEN1
SCHEMBL7128853 0.90 MAPT (0.62) RAB9AMAPTKMT2APOLBABL1
SCHEMBL7129934 0.89 RAB9A (0.56) RAB9AMAPTKMT2APOLBABL1
SCHEMBL7119667 0.88 RAB9A (0.53) RAB9AMAPTKMT2APOLBMEN1
SCHEMBL7125386 0.88 RAB9A (0.59) RAB9AMAPTKMT2APOLBABL1
SCHEMBL7128794 0.88 MEN1 (0.69) RAB9AMAPTKMT2APOLBMEN1
SCHEMBL7127621 0.88 ABL1 (0.63) RAB9AMAPTKMT2APOLBABL1
SCHEMBL7125353 0.87 RAB9A (0.59) RAB9AMAPTKMT2APOLBMEN1
SCHEMBL7123649 0.86 MEN1 (0.62) RAB9AMAPTKMT2AABL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US claimed
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD RAB9A 1179/4885MAPT 4391/4885KMT2A 3291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.